According to a recent research report titled “U.S. Over the Counter (OTC) Drugs Market (By Product Type: Vitamin and Dietary Supplements, Cough and Cold Products, Analgesics, Gastrointestinal Products, Sleep Aids, Otic Products, Wart Removers, Mouth Care Products, Ophthalmic Products, Botanicals, Antacids, Smoking Cessation Products, Feminine Care, Others; By Dosage Form; By Route of Administration; By Distribution Channel) – Industry Analysis, Size, Share, Growth, Trends, and Forecast 2024-2033″ published by Precedence Research, the global U.S. over the counter (OTC) drugs market size is projected to touch around USD 41.72 billion by 2033 and growing at a CAGR of 6.42% over the forecast period 2024 to 2033. This comprehensive study examines various factors and their impact on the growth of the U.S. over the counter (OTC) drugs market.
Key Points
- By product type, the cough & cold products segment held the largest share of the market in 2023, the segment is observed to witness a notable growth during the forecast period.
- By dosage form, the tablets segment dominated the market with the largest share in 2023.
- By route of administration, the oral segment held the largest share of the market and is expected to sustain the position throughout the forecast period.
- By distribution channel, the drug stores & retail pharmacies segment dominated the U.S. over the counter (OTC) drugs market in 2023.
The report primarily focuses on the volume and value of the U.S. over the counter (OTC) drugs market at the global, regional, and company levels. At the global level, the report analyzes historical data and future prospects to present an overview of the overall market size. Regionally, the study emphasizes key regions such as North America, Europe, the Middle East & Africa, Latin America, and others.
Furthermore, the research report provides specific segmentations based on regions (countries), companies, and all market segments. This analysis offers insights into the growth and revenue trends during the historical period of 2017 to 2032, as well as the projected period. By understanding these segments, it becomes possible to identify the significance of different factors that contribute to market growth.
Download a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/3753
The research also highlights significant progressions in both organic and inorganic growth strategies within the global U.S. over the counter (OTC) drugs market. Numerous companies are placing emphasis on new product launches, gaining product approvals, and implementing various business expansion tactics. Moreover, the report presents detailed profiles of firms operating in the U.S. over the counter (OTC) drugs market, along with their respective market strategies. Additionally, the study concentrates on prominent industry participants, furnishing details such as company profiles, product offerings, financial updates, and noteworthy advancements.
U.S. Over the Counter (OTC) Drugs Market Scope
| Report Coverage | Details |
| Growth Rate from 2024 to 2033 | CAGR of 6.42% |
| U.S. Market Size in 2023 | USD 23.03 Billion |
| U.S. Market Size by 2033 | USD 41.72 Billion |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Product Type, By Dosage Form, By Route of Administration, and By Distribution Channel |
Also read: Artificial Intelligence Engineering Market Size, Share Report by 2033
Major Key Points Covered in Report:
Executive Summary: It includes key trends of the electric vehicle fuel cell market related to products, applications, and other crucial factors. It also provides analysis of the competitive landscape and CAGR and market size of the electric vehicle fuel cell market based on production and revenue.
Production and Consumption by Region: It covers all regional markets to which the research study relates. Prices and key players in addition to production and consumption in each regional market are discussed.
Key Players: Here, the report throws light on financial ratios, pricing structure, production cost, gross profit, sales volume, revenue, and gross margin of leading and prominent companies competing in the Electric vehicle fuel cell market.
Market Segments: This part of the report discusses product, application and other segments of the electric vehicle fuel cell market based on market share, CAGR, market size, and various other factors.
Research Methodology: This section discusses the research methodology and approach used to prepare the report. It covers data triangulation, market breakdown, market size estimation, and research design and/or programs.
Market Key Players
The report incorporates company profiles of key players in the market. These profiles encompass vital information such as product portfolio, key strategies, and a comprehensive SWOT analysis for each player. Additionally, the report presents a matrix illustrating the presence of each prominent player, enabling readers to gain actionable insights. This facilitates a thoughtful assessment of the market status and aids in predicting the level of competition in the U.S. over the counter (OTC) drugs market.
Key Market Players
- Bayer AG
- Takeda Pharmaceutical Company Ltd.
- Pfizer
- Johnson & Johnson Services Inc.
- Sanofi S.A.
- Novartis AG
- Boehringer Ingelheim International GmbH
- GlaxoSmithKline PLC
- Mylan
- UPM Pharmaceuticals
Segments Covered in the Report
By Product Type
- Vitamin and Dietary Supplements
- Cough & Cold Products
- Analgesics
- Gastrointestinal Products
- Sleep Aids
- Otic Products
- Wart Removers
- Mouth Care Products
- Ophthalmic Products
- Botanicals
- Antacids
- Smoking Cessation Products
- Feminine Care
- Others
By Dosage Form
- Tablets
- Hard Capsules
- Powders
- Ointments
- Soft Capsules
- Liquids
- Others
By Route of Administration
- Oral
- Parenteral
- Topical
- Others
By Distribution Channel
- Drug Stores & Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
Table of Content:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on U.S. Over the Counter (OTC) Drugs Market
5.1. COVID-19 Landscape: U.S. Over the Counter (OTC) Drugs Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. U.S. Over the Counter (OTC) Drugs Market, By Product Type
8.1. U.S. Over the Counter (OTC) Drugs Market Revenue and Volume Forecast, by Product Type, 2024-2033
8.1.1. Vitamin and Dietary Supplements
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Cough & Cold Products
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. Analgesics
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
8.1.4. Gastrointestinal Products
8.1.4.1. Market Revenue and Volume Forecast (2021-2033)
8.1.5. Sleep Aids
8.1.5.1. Market Revenue and Volume Forecast (2021-2033)
8.1.6. Otic Products
8.1.6.1. Market Revenue and Volume Forecast (2021-2033)
8.1.7. Wart Removers
8.1.7.1. Market Revenue and Volume Forecast (2021-2033)
8.1.8. Mouth Care Products
8.1.8.1. Market Revenue and Volume Forecast (2021-2033)
8.1.9. Ophthalmic Products
8.1.9.1. Market Revenue and Volume Forecast (2021-2033)
8.1.10. Botanicals
8.1.10.1. Market Revenue and Volume Forecast (2021-2033)
8.1.11. Antacids
8.1.11.1. Market Revenue and Volume Forecast (2021-2033)
8.1.12. Smoking Cessation Products
8.1.12.1. Market Revenue and Volume Forecast (2021-2033)
8.1.13. Feminine Care
8.1.13.1. Market Revenue and Volume Forecast (2021-2033)
8.1.14. Others
8.1.14.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. U.S. Over the Counter (OTC) Drugs Market, By Dosage Form
9.1. U.S. Over the Counter (OTC) Drugs Market Revenue and Volume Forecast, by Dosage Form, 2024-2033
9.1.1. Tablets
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Hard Capsules
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
9.1.3. Powders
9.1.3.1. Market Revenue and Volume Forecast (2021-2033)
9.1.4. Ointments
9.1.4.1. Market Revenue and Volume Forecast (2021-2033)
9.1.5. Soft Capsules
9.1.5.1. Market Revenue and Volume Forecast (2021-2033)
9.1.6. Liquids
9.1.6.1. Market Revenue and Volume Forecast (2021-2033)
9.1.7. Others
9.1.7.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 10. U.S. Over the Counter (OTC) Drugs Market, By Route of Administration
10.1. U.S. Over the Counter (OTC) Drugs Market Revenue and Volume Forecast, by Route of Administration, 2024-2033
10.1.1. Oral
10.1.1.1. Market Revenue and Volume Forecast (2021-2033)
10.1.2. Parenteral
10.1.2.1. Market Revenue and Volume Forecast (2021-2033)
10.1.3. Topical
10.1.3.1. Market Revenue and Volume Forecast (2021-2033)
10.1.4. Others
10.1.4.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 11. U.S. Over the Counter (OTC) Drugs Market, By Distribution Channel
11.1. U.S. Over the Counter (OTC) Drugs Market Revenue and Volume Forecast, by Distribution Channel, 2024-2033
11.1.1. Drug Stores & Retail Pharmacies
11.1.1.1. Market Revenue and Volume Forecast (2021-2033)
11.1.2. Hospital Pharmacies
11.1.2.1. Market Revenue and Volume Forecast (2021-2033)
11.1.3. Online Pharmacies
11.1.3.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 12. U.S. Over the Counter (OTC) Drugs Market and Trend Forecast
12.1. U.S.
12.1.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)
12.1.2. Market Revenue and Volume Forecast, by Dosage Form (2021-2033)
12.1.3. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)
12.1.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
Chapter 13. Company Profiles
13.1. Bayer AG
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Takeda Pharmaceutical Company Ltd.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Pfizer
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Johnson & Johnson Services Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Sanofi S.A.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Novartis AG
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Boehringer Ingelheim International GmbH
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. GlaxoSmithKline PLC
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Mylan
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. UPM Pharmaceuticals
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Why should you invest in this report?
This report presents a compelling investment opportunity for those interested in the global U.S. over the counter (OTC) drugs market. It serves as an extensive and informative guide, offering clear insights into this niche market. By delving into the report, you will gain a comprehensive understanding of the various major application areas for U.S. over the counter (OTC) drugs. Furthermore, it provides crucial information about the key regions worldwide that are expected to experience substantial growth within the forecast period of 2023-2030. Armed with this knowledge, you can strategically plan your market entry approaches.
Moreover, this report offers a deep analysis of the competitive landscape, equipping you with valuable insights into the level of competition prevalent in this highly competitive market. If you are already an established player, it will enable you to assess the strategies employed by your competitors, allowing you to stay ahead as market leaders. For newcomers entering this market, the extensive data provided in this report is invaluable, providing a solid foundation for informed decision-making.
Some of the key questions answered in this report:
- What is the size of the overall U.S. over the counter (OTC) drugs market and its segments?
- What are the key segments and sub-segments in the market?
- What are the key drivers, restraints, opportunities and challenges of the U.S. over the counter (OTC) drugs market and how they are expected to impact the market?
- What are the attractive investment opportunities within the U.S. over the counter (OTC) drugs market?
- What is the U.S. over the counter (OTC) drugs market size at the regional and country-level?
- Who are the key market players and their key competitors?
- What are the strategies for growth adopted by the key players in U.S. over the counter (OTC) drugs market?
- What are the recent trends in U.S. over the counter (OTC) drugs market? (M&A, partnerships, new product developments, expansions)?
- What are the challenges to the U.S. over the counter (OTC) drugs market growth?
- What are the key market trends impacting the growth of U.S. over the counter (OTC) drugs market?
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
